MedChemExpress MCE - Products
MedChemExpress (MCE) offers a wide range of high-quality research chemicals and biochemicals (novel life-science reagents, reference compounds and natural compounds) for scientific use.
| Product | Description | |
|---|---|---|
| Monoethylglycinexylidide | Monoethylglycinexylidide is a metabolite of Lidocain (HY-B0185) via oxidative N-deethylation of Lignocaine by liver cytochrome P-450 enzymes in the liver[1]. Uses: Scientific research. Category: Signaling pathways. CAS No. 7728-40-7. Pack Sizes: 10 mM * 1 mL in DMSO; 10 mg; 25 mg; 50 mg; 100 mg. Product ID: HY-118167. |  |
| Monoisobutyl phthalic acid | Monoisobutyl phthalic acid is a phthalate metabolite that is in human semen and in meconium. Uses: Scientific research. Category: Signaling pathways. CAS No. 30833-53-5. Pack Sizes: 10 mM * 1 mL in Methanol; 5 mg; 10 mg. Product ID: HY-113220. | |
| Monomethyl auristatin E | Monomethyl auristatin E (MMAE; SGD-1010) is a synthetic derivative of dolastatin 10 and functions as a potent mitotic inhibitor by inhibiting tubulin polymerization. MMAE is widely used as a cytotoxic component of antibody-drug conjugates (ADCs) to treat several different cancer types. Uses: Scientific research. Category: Signaling pathways. Alternative Names: MMAE; SGD-1010. CAS No. 474645-27-7. Pack Sizes: 5 mg; 10 mg; 25 mg; 50 mg; 100 mg; 250 mg; 500 mg; 1 g. Product ID: HY-15162. | |
| Monomethyl auristatin E (GMP) | Monomethyl auristatin E (MMAE) (GMP) is Monomethyl auristatin E (HY-15162) produced by using GMP guidelines. Monomethyl auristatin E is a tubulin polymerization inhibitor[1]. Uses: Scientific research. Category: Signaling pathways. Alternative Names: MMAE (GMP); SGD-1010 (GMP); Vedotin (GMP). CAS No. 474645-27-7. Pack Sizes: 10 mg; 25 mg; 50 mg; 100 mg. Product ID: HY-15162G. | |
| Monomethyl auristatin E intermediate-1 | Monomethyl auristatin E intermediate-1 is an intermediate reagent in the synthesis of Monomethyl auristatin E (HY-15162). Monomethyl auristatin E (MMAE) is a microtubule/tubulin inhibitor with anticancer activity. MMAE is widely used as the cytotoxic component (ADC Cytotoxin) of antibody-drug conjugates (ADCs)[1]. Uses: Scientific research. Category: Signaling pathways. CAS No. 120205-48-3. Pack Sizes: 10 mM * 1 mL in DMSO; 50 mg; 100 mg; 250 mg; 1 g; 5 g; 10 g; 25 g. Product ID: HY-33048. | |
| Monomethyl auristatin E (Standard) | Monomethyl auristatin E (MMAE) (Standard) is the analytical standard of Monomethyl auristatin E (HY-15162). This product is intended for research and analytical applications. Monomethyl auristatin E is a synthetic derivative of dolastatin 10 and functions as a potent mitotic inhibitor by inhibiting tubulin polymerization. MMAE is widely used as a cytotoxic component of antibody-drug conjugates (ADCs) against several different cancer types[1]. Uses: Scientific research. Category: Signaling pathways. Alternative Names: MMAE (Standard); SGD-1010 (Standard); Vedotin (Standard). CAS No. 474645-27-7. Pack Sizes: 5 mg; 10 mg; 25 mg; 50 mg; 100 mg. Product ID: HY-15162R. | |
| Monomethyl fumarate | Monomethyl fumarate, an active metabolite of Dimethyl fumarate (DMF), is a potent GPR109A agonist. Monomethyl fumarate has the potential for multiple neuroprotective pathways and other models of retinal disease[1][2][3]. Uses: Scientific research. Category: Signaling pathways. CAS No. 2756-87-8. Pack Sizes: 10 mM * 1 mL in DMSO; 500 mg. Product ID: HY-103252. | |
| Monomethyl fumarate-d3 | Monomethyl fumarate-d3 is a deuterium labeled Monomethyl fumarate (HY-103252). Monomethyl fumarate, an active metabolite of Dimethyl fumarate (DMF) (HY-17363), is a potent GPR109A agonist. Monomethyl fumarate has the potential for multiple neuroprotective pathways and other models of retinal disease[1][2][3]. Uses: Scientific research. Category: Signaling pathways. CAS No. 1616345-41-5. Pack Sizes: 1 mg; 5 mg. Product ID: HY-103252S. | |
| Monophosphoryl lipid A | Monophosphoryl lipid A (Glucopyranosyl lipid A) is a toll-like receptor 4 agonist. Monophosphoryl lipid A is derived from the cell wall of nonpathogenic Salmonella. Monophosphoryl lipid A can be used for the research of immunization and vaccine[1]. Uses: Scientific research. Category: Signaling pathways. Alternative Names: Glucopyranosyl lipid A. CAS No. 1246298-63-4. Pack Sizes: 100 μg; 1 mg. Product ID: HY-130320. | |
| Monotropein | Monotropein is an iridoid glycoside that can be isolated from the roots of Morinda officinalis. Monotropein inhibits the expression of inflammatory mediators in dextran sulfate sodium (DSS)-induced colitis mouse model. Monotropein exerts protective effects against IL-1β-induced apoptosis and catabolic responses on osteoarthritis chondrocytes. Monotropein has cartilage protective activity. Monotropein can alleviate Cisplatin (HY-17394)-induced acute kidney injury by inhibiting oxidative damage, inflammation and apoptosis through activation of Nrf2/HO-1 pathway and inhibition of NF-κB signaling. Monotropein can be studied in research for osteoarthritis, acute kidney injury and acute lung injury[1][2][3]. Uses: Scientific research. Category: Signaling pathways. CAS No. 5945-50-6. Pack Sizes: 10 mM * 1 mL in Water; 5 mg; 10 mg; 25 mg; 50 mg; 100 mg. Product ID: HY-N0648. | |
| Montelukast | Montelukast (MK0476 free base) is a potent, selective and orally active antagonist of cysteinyl leukotriene receptor 1 (CysLT1). Montelukast can be used for the reseach of asthma and liver injury. Montelukast also has an antioxidant effect in intestinal ischemia-reperfusion injury, and could reduce cardiac damage. Montelukast decreases eosinophil infiltration into the asthmatic airways. Montelukast can also be used for COVID-19 research[1][2][3][4]. Uses: Scientific research. Category: Signaling pathways. Alternative Names: MK0476 free base. CAS No. 158966-92-8. Pack Sizes: 10 mM * 1 mL in DMSO; 50 mg; 100 mg. Product ID: HY-13315A. | |
| Montelukast impurity 10 | Montelukast impurity 10 is an impurity of Montelukast. Uses: Scientific research. Category: Signaling pathways. CAS No. 1258428-71-5. Pack Sizes: 5 mg; 10 mg. Product ID: HY-Z12066. | |
| Montelukast impurity 3 | Montelukast impurity 3 is an impurity of Montelukast. Uses: Scientific research. Category: Signaling pathways. CAS No. 918972-54-0. Pack Sizes: 5 mg; 10 mg; 25 mg; 50 mg. Product ID: HY-Z4508. | |
| Montelukast sodium | Montelukast sodium (MK0476) is a potent, selective and orally active antagonist of cysteinyl leukotriene receptor 1 (CysLT1). Montelukast sodium can be used for the reseach of asthma and liver injury. Montelukast sodium also has an antioxidant effect in intestinal ischemia-reperfusion injury, and could reduce cardiac damage. Montelukast sodium decreases eosinophil infiltration into the asthmatic airways. Montelukast sodium can also be used for COVID-19 research[1][2][3][4]. Uses: Scientific research. Category: Signaling pathways. Alternative Names: MK0476. CAS No. 151767-02-1. Pack Sizes: 10 mM * 1 mL in DMSO; 50 mg; 100 mg; 500 mg. Product ID: HY-13315. | |
| MOPS | MOPS is a buffering agent used in biology. MOPS buffer maintains the pH of mammalian cell culture media. MOPS significantly improves the thermal stability of BSA (HY-D0842)[1][2][3]. Uses: Scientific research. Category: Signaling pathways. CAS No. 1132-61-2. Pack Sizes: 10 mM * 1 mL in Water; 10 g; 25 g; 50 g; 100 g. Product ID: HY-D0859. | |
| MOPS sodium salt | MOPS sodium salt is a buffering agent used in biology. MOPS buffer maintains the pH of mammalian cell culture media. MOPS sodium salt significantly improves the thermal stability of BSA (HY-D0842)[1][2][3]. Uses: Scientific research. Category: Signaling pathways. CAS No. 71119-22-7. Pack Sizes: 10 mM * 1 mL in DMSO; 10 g; 25 g; 50 g; 100 g; 500 g; 1 k g. Product ID: HY-D0859A. | |
| MOR-106 | MOR-106 (MOR12743) is a humanized anti-IL-17C IgG1 monoclonal antibody. MOR-106 inhibits the NF-κB signaling pathway by specifically binding to IL-17C (IC50 = 59 pM for human IL-17C, IC50 = 55 pM for mouse IL-17C). MOR-106 can effectively inhibit skin inflammation and reduce related inflammatory factors in animal models of psoriasis and atopic dermatitis[1][2]. Uses: Scientific research. Category: Signaling pathways. Alternative Names: MOR12743; MOR03207. CAS No. 2304625-87-2. Pack Sizes: 1 mg; 5 mg; 10 mg. Product ID: HY-P991598. | |
| Moracin C | Moracin C, a natural product, is an anti-inflammatory agent. Moracin C inhibits LPS-activated reactive oxygen species (ROS) and nitric oxide (NO) release from cells[1]. Uses: Scientific research. Category: Signaling pathways. CAS No. 69120-06-5. Pack Sizes: 1 mg; 5 mg; 10 mg. Product ID: HY-N3245. | |
| Moracin M | Moracin M is a phenolic component that can be isolated from Mori Cortex, is a potent phosphodiesterase-4 (PDE4) inhibitor with IC50 values of 2.9, 4.5, >40, and >100 μM for PDE4D2, PDE4B2, PDE5A1, and PDE9A2, respectively. Moracin M has anti-inflammatory activity[1][2]. Uses: Scientific research. Category: Signaling pathways. CAS No. 56317-21-6. Pack Sizes: 10 mM * 1 mL in DMSO; 5 mg; 10 mg; 50 mg; 100 mg. Product ID: HY-122942. | |
| Moracin N | Moracin N is a ferroptosis inhibitor that can be isolated from mulberry leaf. Moracin N exerts neuroprotective activity through preventing from oxidative stress[1]. Uses: Scientific research. Category: Signaling pathways. CAS No. 135248-05-4. Pack Sizes: 1 mg; 5 mg; 10 mg. Product ID: HY-N11849. | |
| Moracin O | Moracin O is a 2-arylbenzofuran isolated from the Morus alba Linn. Moracin O exhibits potent in vitro inhibitory activity against hypoxia-inducible factor (HIF-1). Moracin O reduces oxygen-glucose deprivation (OGD)-induced reactive oxygen species (ROS) production. Moracin O has neuroprotective and anti-inflammatory effects[1][2][3]. Uses: Scientific research. Category: Signaling pathways. CAS No. 123702-97-6. Pack Sizes: 10 mM * 1 mL in DMSO; 1 mg; 5 mg. Product ID: HY-N3244. | |
| Moracin P | Moracin P is a 2-arylbenzofuran isolated from the Mori Cortex Radicis. Moracin P exhibits potent in vitro inhibitory activity against hypoxia-inducible factor (HIF-1). Moracin P reduces oxygen-glucose deprivation (OGD)-induced reactive oxygen species (ROS) production. Moracin P has neuroprotective and anti-inflammatory effects[1][2][3]. Uses: Scientific research. Category: Signaling pathways. CAS No. 102841-46-3. Pack Sizes: 5 mg; 10 mg. Product ID: HY-N3243. | |
| Morelloflavone | Morelloflavone has antioxidative, antiviral, and anti-inflammatory properties. Uses: Scientific research. Category: Signaling pathways. CAS No. 16851-21-1. Pack Sizes: 1 mg; 5 mg. Product ID: HY-N10276. | |
| Moricizine-d8Hydrochloride | Moricizine-d8 Hydrochloride is the deuterium labeled Moricizine Hydrochloride (HY-B0615A). Moricizine Hydrochloride is an orally active Class I antiarrhythmic agent. Moricizine Hydrochloride decreases the maximum rate of phase 0 depolarization; increases rates of phase 2 and 3 repolarization, decreases action potential duration, and decreases effective refractory period[1][2]. Uses: Scientific research. Category: Signaling pathways. Alternative Names: EN 313-d8; Ethmozin-d8; Moracizine-d8. CAS No. 2300178-76-9. Pack Sizes: 1 mg; 5 mg. Product ID: HY-B0615AS. | |
| Morin | Morin is an orally active plant-derived flavonoid. Morin inhibits ROS generation. Morin induces Apoptosis. Morin inhibits PTP1B (IC50 of 15 μM) and activates the insulin receptor. Morin has a detoxifying effect. Morin can be used in diabetes, leukemia, colon cancer, cervical cancer, Parkinson's disease and hypertension research[1][2][3][4][5][6][7][8][9][10][11][12]. Uses: Scientific research. Category: Signaling pathways. CAS No. 480-16-0. Pack Sizes: 10 mM * 1 mL in DMSO; 1 mg; 5 mg; 10 mg; 25 mg; 50 mg; 100 mg. Product ID: HY-N0621. | |
| Moringin | Moringin is a potent and selective TRPA1 ion channel natural agonist with an EC50 of 3.14 μM. Moringin does not activate or activates very weakly the vanilloids somatosensory channels TRPV1, TRPV2, TRPV3 and TRPV4, and the melastatin cooling receptor TRPM8. Moringin has hypoglycemic, antimicrobial, anti-inflammatory, anticancer and neuroprotection activities[1][2]. Uses: Scientific research. Category: Signaling pathways. CAS No. 73255-40-0. Pack Sizes: 10 mM * 1 mL in DMSO; 5 mg; 10 mg. Product ID: HY-N8264. | |
| Morinidazole | Morinidazole is an orally active and 5-nitroimidazole antimicrobial agent that undergoes extensive metabolism in humans via N+-glucuronidation and sulfation. Morinidazole can be used for bacterial infections research including appendicitis and pelvic inflammatory disease (PID) caused by anaerobic bacteria[1]. Uses: Scientific research. Category: Signaling pathways. CAS No. 92478-27-8. Pack Sizes: 10 mM * 1 mL in DMSO; 5 mg; 10 mg; 25 mg; 50 mg; 100 mg; 250 mg; 500 mg; 1 g. Product ID: HY-15781. | |
| Morphothiadin | Morphothiadin is a potent inhibitor on the replication of both wild-type and adefovir (HY-B1826)-resistant HBV with an IC50 of 12 nM. Uses: Scientific research. Category: Signaling pathways. Alternative Names: GLS4. CAS No. 1092970-12-1. Pack Sizes: 10 mM * 1 mL in DMSO; 1 mg; 5 mg; 10 mg; 25 mg; 50 mg; 100 mg. Product ID: HY-108917. | |
| Morusin | Morusin is a prenylated flavonoid isolated from Morus alba Linn. with various biological activities, such as antitumor, antioxidant, and anti-bacteria property. Morusin could inhibit NF-κB and STAT3 activity. Uses: Scientific research. Category: Signaling pathways. Alternative Names: Mulberrochromene. CAS No. 62596-29-6. Pack Sizes: 10 mM * 1 mL in DMSO; 5 mg; 10 mg; 25 mg. Product ID: HY-N0622. | |
| Mosapride citrate dihydrate | Mosapride (TAK-370) citrate dehydrate is a gastroprokinetic agent with 5-hydroxytryptamine4 receptor agonist activity and has been widely used in the research of a variety of gastrointestinal disorders. Mosapride citrate dihydrate potently inhibits Kv4.3 in a concentration-dependent manner with IC50 values of 15.2 μM[1]. Mosapride citrate dihydrateselectively stimulates upper GI motility in vivo[2]. Uses: Scientific research. Category: Signaling pathways. Alternative Names: TAK-370 citrate dihydrate; AS-4370 citrate dihydrate. CAS No. 636582-62-2. Pack Sizes: 5 mg; 10 mg; 25 mg; 50 mg; 100 mg. Product ID: HY-B0189B. | |
| Mosnodenvir | Mosnodenvir (JNJ-1802) is an orally active pan serotype dengue virus (DENV) inhibitor, with EC50 values ranging from 0.057 to 11 nM for four dengue virus (DENV) serotypes. Mosnodenvir blocks viral replication by inhibiting the formation of complexes between two viral proteins, nonstructural protein 3 (NS3) and NS4B, thereby preventing the formation of new viral RNA. Mosnodenvir exhibits picomolar to nanomolar antiviral activity in vitro and has antiviral efficacy in mice and non-human primates[1][2]. Uses: Scientific research. Category: Signaling pathways. Alternative Names: JNJ-1802. CAS No. 2890688-86-3. Pack Sizes: 10 mM * 1 mL in DMSO; 5 mg; 10 mg. Product ID: HY-153810. | |
| Mosperafenib | BRAF inhibitor. RG6344 can be used for the study of BRAF V600-mutant solid tumors, such as colorectal cancer (CRC)[1]. Uses: Scientific research. Category: Signaling pathways. Alternative Names: RG6344; RO7276389; B-Raf IN 2. CAS No. 2649372-20-1. Pack Sizes: 10 mM * 1 mL in DMSO; 5 mg; 10 mg; 25 mg; 50 mg; 100 mg. Product ID: HY-145120. | |
| Mosunetuzumab | Mosunetuzumab (BTCT-4465A) is a full-length, fully humanized immunoglobulin G1 (IgG1) T-cell-dependent bispecific (TDB) antibody targeting CD20 (B cells) and CD3 (T cells). Mosunetuzumab redirects T cells to engage and eliminate malignant B cells and can be used for the research of relapsed or refractory (R/R) B-cell non-Hodgkin lymphomas (B-NHLs)[1][2]. Uses: Scientific research. Category: Signaling pathways. Alternative Names: BTCT-4465A; RG-7828; RO7030816. CAS No. 1905409-39-3. Pack Sizes: 1 mg; 5 mg; 10 mg; 25 mg; 50 mg; 100 mg. Product ID: HY-P99033. | |
| Motavizumab | Motavizumab (MEDI-524) is an anti-human RSV (respiratory syncytial virus) monoclonal antibody. Motavizumab can be used in respiratory syncytial virus infection in high-risk infants research[1]. Uses: Scientific research. Category: Signaling pathways. Alternative Names: MEDI-524. CAS No. 677010-34-3. Pack Sizes: 1 mg; 5 mg; 10 mg. Product ID: HY-P99209. | |
| Motesanib | Motesanib (AMG 706) is a potent ATP-competitive inhibitor of VEGFR1/2/3 with IC50s of 2 nM/3 nM/6 nM, respectively, and has similar activity against Kit, and is appr 10-fold more selective for VEGFR than PDGFR and Ret. Uses: Scientific research. Category: Signaling pathways. Alternative Names: AMG 706. CAS No. 453562-69-1. Pack Sizes: 10 mM * 1 mL in DMSO; 5 mg; 10 mg; 25 mg; 50 mg; 100 mg; 500 mg. Product ID: HY-10228. | |
| Motilin (26-47), human, porcine | Motilin (26-47), human, porcine is an endogenous motilin receptor ligand with Ki and EC50 of 2.3 nM and 0.3 nM in a Chinese hamster ovary cell line. Uses: Scientific research. Category: Signaling pathways. CAS No. 52906-92-0. Pack Sizes: 500 μg; 1 mg; 5 mg; 10 mg. Product ID: HY-P1037. | |
| Motixafortide | Motixafortide (BKT140 4-fluorobenzoyl) is a novel CXCR4 antagonist with an IC50 vakue of ~1 nM. Uses: Scientific research. Category: Signaling pathways. Alternative Names: BKT140 (4-fluorobenzoyl); BL-8040; TF14016. CAS No. 664334-36-5. Pack Sizes: 5 mg; 10 mg; 25 mg; 50 mg; 100 mg. Product ID: HY-P0171. | |
| Motolimod | Motolimod (VTX-2337;VTX-378) is a selective Toll-like receptor 8 (TLR8) agonist, with an EC50 of approximately 100 nM. Uses: Scientific research. Category: Signaling pathways. Alternative Names: VTX-2337; VTX-378. CAS No. 926927-61-9. Pack Sizes: 10 mM * 1 mL in DMSO; 5 mg; 10 mg; 25 mg; 50 mg; 100 mg; 250 mg; 500 mg; 1 g. Product ID: HY-13773. | |
| MOTS-c (human) | MOTS-c (human) is a blood-brain barrier-penetrating, mitochondrial-derived peptide that modulates the AMPK/PGC-1α pathway to enhance insulin sensitivity. MOTS-c (human) inhibits the folate cycle and de novo purine synthesis, increases AICAR levels to activate AMPK, and then regulates the Nrf2/Keap1 antioxidant pathway and inhibits the NF-κB inflammatory pathway, while promoting mitochondrial biogenesis and energy metabolism. MOTS-c (human) has the effects of improving glucose and lipid metabolism, anti-oxidative stress, anti-inflammatory and neuroprotection, and can be used in the study of type 2 diabetes, traumatic brain injury, inflammatory diseases and aging-related metabolic disorders[1][2][3][4]. Uses: Scientific research. Category: Signaling pathways. CAS No. 1627580-64-6. Pack Sizes: 5 mg; 10 mg; 25 mg; 50 mg. Product ID: HY-P2048. | |
| Moxetumomab | Moxetumomab is an anti-CD22 human IgG1 κ monoclonal antibody. Recommend Isotype Controls: Human IgG1 kappa, Isotype Control (HY-P99001)[1][2]. Uses: Scientific research. Category: Signaling pathways. CAS No. 1622075-65-3. Pack Sizes: 1 mg; 5 mg; 10 mg. Product ID: HY-P99034. | |
| Moxidectin | Moxidectin (CL301423) is an orally active and brain-penetrant macrolide (ML) anthelmintic for the prevention and control of heartworms and roundworms. Moxidectin is also a substrate of BCRP and P-glycoprotein (P-gp) in vivo, and is secreted into breast milk and effluxed from the host and parasite mediated by Bcrp1 and P-gp. This may be related to the presence of chemical residues in milk[1][2][3]. Uses: Scientific research. Category: Signaling pathways. Alternative Names: CL301423. CAS No. 113507-06-5. Pack Sizes: 10 mM * 1 mL in DMSO; 5 mg; 10 mg; 25 mg; 50 mg; 100 mg; 500 mg. Product ID: HY-B0777. | |
| Moxifloxacin | Moxifloxacin is an orally active 8-methoxyquinolone antimicrobial for use in the treatment of acute bacterial sinusitis, acute bacterial exacerbations of chronic bronchitis, and community-acquired pneumonia[1][2]. Uses: Scientific research. Category: Signaling pathways. Alternative Names: BAY 12-8039 free base. CAS No. 151096-09-2. Pack Sizes: 100 mg; 500 mg; 1 g. Product ID: HY-66011A. | |
| Moxifloxacin-d4 | Moxifloxacin-d4 is the deuterium labeled Moxifloxacin. Moxifloxacin is an orally active 8-methoxyquinolone antimicrobial for use in the treatment of acute bacterial sinusitis, acute bacterial exacerbations of chronic bronchitis, and community-acquired pneumonia[1][2]. Uses: Scientific research. Category: Signaling pathways. Alternative Names: BAY 12-8039-d4 free base. CAS No. 2596386-23-9. Pack Sizes: 1 mg; 5 mg; 10 mg. Product ID: HY-66011AS. | |
| Moxifloxacin Hydrochloride | Moxifloxacin Hydrochloride (BAY 12-8039) is an oral 8-methoxyquinolone antimicrobial for use in the treatment of acute bacterial sinusitis, acute bacterial exacerbations of chronic bronchitis, and community-acquired pneumonia[1][2]. Uses: Scientific research. Category: Signaling pathways. Alternative Names: BAY 12-8039. CAS No. 186826-86-8. Pack Sizes: 25 mg; 50 mg; 100 mg; 200 mg; 500 mg; 1 g. Product ID: HY-66011. | |
| Moxifloxacin hydrochloride monohydrate | Moxifloxacin (BAY 12-8039) hydrochloride monohydrate is an orally active bacterial inhibitor that is effective against Streptococcus pneumoniae. Moxifloxacin hydrochloride monohydrate can be used in tuberculosis research[1][2]. Uses: Scientific research. Category: Signaling pathways. Alternative Names: BAY 12-8039 monohydrate. CAS No. 192927-63-2. Pack Sizes: 10 mM * 1 mL in DMSO; 250 mg; 500 mg; 1 g. Product ID: HY-W353258. | |
| Moxifloxacin (Standard) | Moxifloxacin (Standard) is the analytical standard of Moxifloxacin. This product is intended for research and analytical applications. Moxifloxacin is an orally active 8-methoxyquinolone antimicrobial for use in the treatment of acute bacterial sinusitis, acute bacterial exacerbations of chronic bronchitis, and community-acquired pneumonia[1][2]. Uses: Scientific research. Category: Signaling pathways. Alternative Names: BAY 12-8039 free base (Standard). CAS No. 151096-09-2. Pack Sizes: 5 mg; 10 mg; 25 mg; 50 mg; 100 mg. Product ID: HY-66011AR. | |
| Moxilubant | Moxilubant (CGS 25019C free base) is an orally active BLT1 antagonist. Moxilubant inhibits LTB4 signaling with a potency of 2-4 nM. Moxilubant blocks LTB4-induced neutrophil functions. Moxilubant inhibits ear edema and neutrophil infiltration in mice. Moxilubant can be used in research related to chronic obstructive pulmonary disease[1][2]. Uses: Scientific research. Category: Signaling pathways. Alternative Names: CGS 25019C free base. CAS No. 146978-48-5. Pack Sizes: 10 mM * 1 mL in DMSO; 5 mg; 10 mg. Product ID: HY-106929. | |
| Moxonidine hydrochloride | Moxonidine (BDF5895) hydrochloride is an orally active imidazoline type 1 receptor (I1-R) agonist. Moxonidine hydrochloride activates imidazoline I1 receptors and α2 adrenoceptors, affecting oxidized low-density lipoprotein uptake. Moxonidine hydrochloride reduces atherosclerotic lesions and lowers blood pressure. Moxonidine hydrochloride can be used in the study of hypertension, heart failure, and atherosclerosis[1][2][3][4][5][6][7]. Uses: Scientific research. Category: Signaling pathways. Alternative Names: BDF5895 hydrochloride. CAS No. 75536-04-8. Pack Sizes: 10 mM * 1 mL in DMSO; 5 mg; 10 mg; 25 mg; 50 mg; 100 mg. Product ID: HY-B0374A. | |
| Mozavaptan | Mozavaptan (OPC-31260) is a benzazepine derivative and a potent, selective, competitive and orally active vasopressin V2 receptor antagonist with an IC50 of 14 nM. Mozavaptan shows ~85-fold selectivity for V2 receptor over V1 receptor (IC50 of 1.2 μM), and can antagonize the antidiuretic action of arginine vasopressin (AVP) in vivo. Mozavaptan has the potential for hyponatremia, syndrome of inappropriate antidiuretic hormone (SIADH), and congestive heart failure treatment[1][2]. Uses: Scientific research. Category: Signaling pathways. Alternative Names: OPC-31260. CAS No. 137975-06-5. Pack Sizes: 10 mM * 1 mL in DMSO; 5 mg; 10 mg; 25 mg; 50 mg; 100 mg; 250 mg. Product ID: HY-18346. | |
| Mozavaptan hydrochloride | Mozavaptan hydrochloride (OPC-31260 hydrochloride) is a benzazepine derivative and a potent, selective, competitive and orally active vasopressin V2 receptor antagonist with an IC50 of 14 nM. Mozavaptan hydrochloride shows ~85-fold selectivity for V2 receptor over V1 receptor (IC50 of 1.2 μM), and can antagonize the antidiuretic action of arginine vasopressin (AVP) in vivo. Mozavaptan hydrochloride has the potential for hyponatremia, syndrome of inappropriate antidiuretic hormone (SIADH), and congestive heart failure treatment[1][2]. Uses: Scientific research. Category: Signaling pathways. Alternative Names: OPC-31260 hydrochloride. CAS No. 138470-70-9. Pack Sizes: 10 mM * 1 mL in DMSO; 5 mg; 10 mg; 25 mg; 50 mg; 100 mg. Product ID: HY-123593. | |
| MP07-66 | MP07-66, a FTY720 analogue, is devoid of immunosuppressive effects and shows promising antitumor effects in chronic lymphocytic leukemia by disruption of the SET-PP2A complex leading to PP2A reactivation[1]. Uses: Scientific research. Category: Signaling pathways. CAS No. 1938056-90-6. Pack Sizes: 10 mM * 1 mL in DMSO; 5 mg; 10 mg; 25 mg; 50 mg; 100 mg. Product ID: HY-123794. | |
| MP7 | MP7 (PDK1 inhibitor) is a phosphoinositide-dependent kinase-1 (PDK1) inhibitor. Uses: Scientific research. Category: Signaling pathways. Alternative Names: PDK1 inhibitor. CAS No. 1001409-50-2. Pack Sizes: 10 mM * 1 mL in DMSO; 5 mg; 10 mg; 25 mg; 50 mg; 100 mg. Product ID: HY-14440. | |
| m-PEG10000-NHS ester | m-PEG10000-NHS ester is a PEG-based PROTAC linker that can be used in the synthesis of PROTACs[1]. Uses: Scientific research. Category: Signaling pathways. Alternative Names: mPEG10000-SC; mPEG10000-Succinimidyl ester. CAS No. 92451-01-9. Pack Sizes: 25 mg; 50 mg; 100 mg; 250 mg; 500 mg; 1 g. Product ID: HY-140699. | |
| mPEG1000-amine | mPEG1000-amine (mPEG1000-NH2) is a class of functionalized polymers composed of a methoxy-terminated polyethylene glycol backbone and a terminal primary amine group. mPEG1000-amine serves as an important intermediate for constructing functionalized nanocarriers, modifying proteins or polypeptides, and developing novel drug delivery systems. Uses: Scientific research. Category: Signaling pathways. Alternative Names: mPEG1000-NH2. CAS No. 80506-64-5. Pack Sizes: 100 mg; 500 mg. Product ID: HY-140675. | |
| m-PEG10-CH2COOH | m-PEG10-CH2COOH is a PEG-based PROTAC linker that can be used in the synthesis of PROTACs[1]. Uses: Scientific research. Category: Signaling pathways. CAS No. 908258-58-2. Pack Sizes: 100 mg; 250 mg; 1 g; 5 g. Product ID: HY-133285. | |
| m-PEG12-acid | m-PEG12-acid is a PEG-based PROTAC linker that can be used in the synthesis of PROTACs[1]. Uses: Scientific research. Category: Signaling pathways. CAS No. 2135793-73-4. Pack Sizes: 50 mg; 100 mg; 250 mg; 1 g; 5 g; 10 g. Product ID: HY-135820. | |
| m-PEG12-NHS ester | m-PEG12-NHS ester is a PEG-based PROTAC linker that can be used in the synthesis of PROTACs[1]. Uses: Scientific research. Category: Signaling pathways. CAS No. 2207596-93-6. Pack Sizes: 100 mg; 500 mg. Product ID: HY-141106. | |
| m-PEG12-OTs | m-PEG12-Ots is a PEG-based PROTAC linker that can be used in the synthesis of PROTACs[1]. Uses: Scientific research. Category: Signaling pathways. CAS No. 2103241-71-8. Pack Sizes: 1 g; 5 g. Product ID: HY-161020. | |
| mPEG2000-amine | mPEG2000-amine (mPEG2000-NH2) is a class of functionalized polymers composed of a methoxy-terminated polyethylene glycol backbone and a terminal primary amine group. mPEG2000-amine serves as an important intermediate for constructing functionalized nanocarriers, modifying proteins or polypeptides, and developing novel drug delivery systems. Uses: Scientific research. Category: Signaling pathways. Alternative Names: mPEG2000-NH2. CAS No. 80506-64-5. Pack Sizes: 50 mg; 100 mg; 250 mg; 1 g; 5 g. Product ID: HY-140676. | |
| mPEG2000-DMG | DMG-PEG 2000 is used for the preparation of liposome for siRNA delivery with improved transfection efficiency in vitro. DMG-PEG 2000 is also used for the lipid nanoparticle for an oral plasmid DNA delivery approach in vivo through a facile surface modification to improve the mucus permeability and delivery efficiency of the nanoparticles[1]. Uses: Scientific research. Category: Signaling pathways. CAS No. 160743-62-4. Pack Sizes: 25 mg; 50 mg; 100 mg; 500 mg. Product ID: HY-112764. | |
| m-PEG2000-NHS ester | m-PEG2000-NHS ester (mPEG2000-SC) is a reagent with both cell adhesion inhibition and peptide conjugation functions. The NHS ester group of m-PEG2000-NHS ester forms stable amide bonds with primary amine-containing molecules (e.g., the N-terminus of MMP-2-cleavable octapeptide) to generate mPEG-peptide intermediates for liposome surface modification. When m-PEG2000-NHS ester is immobilized on a cystamine-modified gold surface, it can construct an in vitro model for cell adhesion kinetic studies, and higher PEG density and thicker layers correlate with lower cell adhesion rates. m-PEG2000-NHS ester can synthesize MMP-2-responsive PEGylated lipid conjugates to achieve MMP-triggered dePEGylation in the tumor microenvironment. m-PEG2000-NHS ester can be used in studies related to colon cancer and other conditions[1][2]. Uses: Scientific research. Category: Signaling pathways. Alternative Names: mPEG2000-SC; mPEG2000-Succinimidyl ester. CAS No. 92451-01-9. Pack Sizes: 100 mg; 250 mg; 500 mg. Product ID: HY-W591424. | |
| m-PEG2000-thiol | m-PEG2000-thiol is a PEG-based PROTAC linker that can be used in the synthesis of PROTACs[1]. Uses: Scientific research. Category: Signaling pathways. Alternative Names: mPEG2000-SH. CAS No. 134874-49-0. Pack Sizes: 100 mg; 250 mg; 1 g; 5 g; 10 g. Product ID: HY-140706. | |
| m-PEG24-alcohol | m-PEG24-alcohol is a PEG-based PROTAC linker that can be used in the synthesis of PROTACs[1]. Uses: Scientific research. Category: Signaling pathways. CAS No. 2376450-73-4. Pack Sizes: 5 mg; 10 mg; 25 mg; 50 mg; 100 mg; 250 mg. Product ID: HY-141225. | |
| m-PEG24-NH2 | m-PEG24-NH2 is a PEG-based PROTAC linker that can be used in the synthesis of PROTACs[1]. Uses: Scientific research. Category: Signaling pathways. CAS No. 2151823-08-2. Pack Sizes: 100 mg; 250 mg; 500 mg; 1 g; 5 g. Product ID: HY-140228. | |
| m-PEG24-NHS ester | m-PEG24-NHS ester is a PEG-based PROTAC linker that can be used in the synthesis of PROTACs[1]. Uses: Scientific research. Category: Signaling pathways. CAS No. 2395839-96-8. Pack Sizes: 5 mg; 10 mg; 25 mg; 50 mg; 100 mg. Product ID: HY-130830. | |
| m-PEG3400-NHS ester | m-PEG3400-NHS ester can be used to modify active molecules and improve their antigenicity, immunogenicity, and help prepare injection preparations. The modification of serine protease lumbrokinase (LK) by m-PEG-NHS ester does not affect its strong fibrinolytic and thrombolytic activities, and has good application prospects. Uses: Scientific research. Category: Signaling pathways. Alternative Names: mPEG3400-SC; mPEG3400-Succinimidyl ester. CAS No. 92451-01-9. Pack Sizes: 10 mg; 25 mg; 50 mg; 100 mg; 250 mg; 500 mg. Product ID: HY-155909. | |
| m-PEG350-thiol | m-PEG350-thiol modifies DNA thiolation for the synthesis of gold nanorods (AuNRs). Thiolated DNA can be loaded onto AuNR by the mPEG-SH/Tween 20 assisted method (Tween 20 and mPEG-SH repeatedly displace CTAB on the AuNR surface). DNA AuNRs have been widely used in nanostructure assembly, gene therapy, biosensing, and drug delivery. Uses: Scientific research. Category: Signaling pathways. Alternative Names: mPEG350-SH. CAS No. 134874-49-0. Pack Sizes: 10 mg; 25 mg; 50 mg; 100 mg. Product ID: HY-W591476D. | |
| m-PEG3-aldehyde | m-PEG3-aldehyde is a PEG-based PROTAC linker can be used in the synthesis of PROTACs. Uses: Scientific research. Category: Signaling pathways. CAS No. 356066-46-1. Pack Sizes: 5 mg; 10 mg; 25 mg; 50 mg; 100 mg. Product ID: HY-124011. | |
| m-PEG3-aldehyde (stabilized with BHT) | m-PEG3-aldehyde (stabilized with BHT) is a PROTAC linker that belongs to the PEG class and can be used in the synthesis of PROTACs[1]. Uses: Scientific research. Category: Signaling pathways. CAS No. 356066-46-1. Pack Sizes: 5 mg; 10 mg; 25 mg; 50 mg; 100 mg. Product ID: HY-124011A. | |
| m-PEG3-Amine | m-PEG3-Amine is a PEG-based PROTAC linker can be used in the synthesis of PROTACs. m-PEG3-Amine is a cleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs)[1]. Uses: Scientific research. Category: Signaling pathways. CAS No. 74654-07-2. Pack Sizes: 5 g; 10 g. Product ID: HY-W018174. | |
Would you like to list your products on USA Chemical Suppliers?
Our database is helping our users find suppliers everyday.